# CGM in Acute Ischemic Stroke

> **NCT07510919** · NA · NOT_YET_RECRUITING · sponsor: **Isala** · enrollment: 82 (estimated)

## Conditions studied

- Acute Ischemic Stroke
- Diabetes (DM)
- Diabetes Type 2
- Hyperglycemia
- Stroke

## Interventions

- **DEVICE:** Continuous Glucose Monitoring
- **DIAGNOSTIC_TEST:** Point-of-Care Testing

## Key facts

- **NCT ID:** NCT07510919
- **Lead sponsor:** Isala
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-04
- **Primary completion:** 2028-05
- **Final completion:** 2028-08
- **Target enrollment:** 82 (ESTIMATED)
- **Last updated:** 2026-04-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07510919

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07510919, "CGM in Acute Ischemic Stroke". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT07510919. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*